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Background: The venous extracranial abnormalities in multiple sclerosis (MS) provide
a new perspective in the treatment. The primary endpoint of our study was to evaluate the
occurrence of venous obstructions in the extracranial venous pathway and the secondary
endpoint to assess the effect of angioplasty on the clinical disability.
Methods: In MS patients with 2 or more of the required 5 sonographic criteria, under
local anaesthesia selective catheter venography (CV) of the azygous (AZY) and the
internal jugular veins (IJVs) was performed.
Results: In our study 158 consecutive MS patients - 39 relapsing-remitting and 119 with
progressive course of disease were included. In 6/158 patients (3.8%) CV did not reveal
any vascular abnormality. The left IJV was more often affected (86%). Restenosis occurred
in 21%. No major side effect was observed. In our study no stents were used. The brain
biopsy tissue of the patients with the tumefactive form of MS demonstrated inflammatory
perivenular changes with intact arteriolar wall. Also an intima thickening of IJV was
found. The important improvement of clinical disability in the relapsing-remitting group
was achieved (p0.001). MS patients with the progressive course of disease reported an
amelioration of the fatigue headache, spasms, bladder dysfunction and quality of life.
Conclusion: Our results support the contribution of venous obstructions in the
extracranial venous pathway to the clinical picture of MS. The removal of venous
abnormalities may importantly influence the degree of clinical disability. Recently, a close
association between venous extracranial abnormalities and the presence of heart disease
was reported.
Other
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Endovascular Treatment of Obesity: Early Results from First in Man Study
Nicholas Kipshidze,1 Akaki Archvadze2
1New York Cardiovascular Research, New York, NY; 2N.Kipshidze Central University
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Introduction: Bariatric surgery proposed for treatment of obesity is often related with
different types of complications and side effects.
Ghrelin, a recently discovered neuropeptide which is predominantly produced in the
gastric fundus, is the only known hormone stimulating food intake (orexigenic hormone).
Catheter-directed left Gastric Artery Chemical Embolization (GACE) performed in
animal models showed to decrease blood ghrelin levels and lead to weight loss.
Here we provide our preliminary results of the First-In-Man study of Left Gastric
Artery Embolization (GAE) safety and efficacy in obese patients.
Methods: 5 patients with different degrees of obesity underwent left GAE with BeadBlock
Embolic Bead 300–500m microspheres (Biocompatibles UK Limited, Chapman House,
Farnham Business Park, Weydon Lane Farnham, Surrey, GU9 8QL, UK).
Gastroscopy was performed in all patients before and after GAE and at 1 week follow
up to rule out significant initial gastritis or ulcer and any worsening after the procedure.
Blood Ghrelin level was also measured before the procedure as well as at 1, 2, 3 and 4
weeks follow up.
Observation on Ghrelin levels and patients’ weight is planned at 3, 6 and 12 month
follow up.
Results: There was no case of periprocedural complications. 3 of 5 patients complained
about slight pain in epigastrium after embolization during first few hours after the
embolization, but control gogastroscopy did not reveal any impairments.
All patients reported significantly decreased appetite in first days after procedure.
Weight loss was observed in all patients at 1 month follow up: mean initial weight -
128.1224.4kg was decreased to 114.8621.3kg and mean initial Body Mass Index
(BMI) - 42.266.8 was decreased to 37.865.7.
Conclusions: Early follow-up has demonstrated that GAE is safe and feasible. It may
become a less invasive and effective method for treatment of obesity.
Further controlled studies enrolling larger number of patients is underway performed to
confirm these initial findings.
Peripheral Vascular Intervention
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Twelve Months Patency Rate After Percutaneous Mechanical Thrombectomy For
Treatment Of Acute Femoropopliteal Bypass Occlusion In 22 Patients
Michael Lichtenberg, Matthias Kaeunicke, Birgit Hailer
Philippusstift Essen, Essen, Germany
Acute and subacute ischemia of the legs in acute and subacute femoropopliteal bypass
occlusion is a dramatic situation that endangers the survival of the limbs, depending on the
severity of the ischemia. Different therapy options like percutaneous mechanical throm-
bectomy procedures, which include rotation thrombectomy, have become available in
recent years in addition to local lysis and surgical thrombectomy. Rotational thrombec-
tomy with the Straub Rotarex® system as an endovascular therapy option has demon-
strated promising results leading to amputation-free survical in multiple studies. We
recently provided data in 22 Patients with acute femoropopliteal bypass occlusion were we
examined the feasibility of the Rotarex® system in this indication. A technical success rate
of 82 % was demonstrated. During a follow up period of 6 months no reinterventions in
these patients had to be performed. We now provide patency rates in 21 patients of our
study group after a follow up period of 12 months. The average ABI after 12 months was
0,80 0,1. One patients showed a hemodynamic restenosis in a Nitinolstent distal to the
femoropopliteal bypass which was implanted in the index procedure. No reocclusion of
the femoropopliteal bypasses occurred in all patients.
6 months
follow up
12 months
follow up
Followed up patients 21/22 21/22
Rutherford stage I (15 patients) I (14 patients)
II (6 patients) II (7 patients)
Walking capacity 323 meter 312 meter
Ankle brachial index (ABI) 0,81 0.1 0,80 0.1
Death 0/21 0/21
Reinterventions 0/21 1/21
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Fractures And Restenosis Of Nitinol Stents In The Superficial Femoral Artery: Is
There An Association?
Anupam Kotwal, Anvar A. Babaev
NYU Langone Medical Center, New York, NY
Background: Maintenance of long-term patency after implantation of Nitinol stent in
the superficial femoral artery (SFA) remains to be one of the most challenging aspects of
endovascular therapy. Studies have made conflicting observations regarding a possible
association between Nitinol stent fractures (SF) in the SFA and development of in-stent
restenosis (ISR).
Methods: We studied 63 consecutive patients (66 limbs) with angiographically con-
firmed obstructive Nitinol self-expandable stent ISR in the SFA. Mean age of the group
was 72.4 7.5 years, 42.4% females, 25.8% smokers, 56% with diabetes. We excluded
patients with Viabhan stents. Stents where evaluated by fluoroscopy/CINE using at least
2 orthogonal views for SF presence. We analyzed SF rates, severity, and angiographic
relationship to ISR pattern and location. Procedural and demographic characteristics such
as: time to ISR, number of stents, stented length, stent diameter and type, run off score,
smoking, age, sex, and presence of comorbidities were analyzed as well.
Results: Mean time from stent implantation to presentation with ISR was 14.5  7.2
months. Out of the 66 limbs with ISR, SF was present in 25 (37.8%) and among those
only 3 (12%) limbs had SF angiographically associated with ISR. SF occurred more
frequently in males (p0.018). Mean stented length was numerically but not statistically
longer in patients with SF than in those without, 221  112 mm vs. 176  98.6 mm
(p0.09) respectively. There were no differences in other procedural and demographic
characteristics between groups with and without SF.
Conclusions: Stent fractures in the SFA play a modest role in the development of ISR.
In our study the association was seen in only 12% of patients with SF. Majority of the
patients with ISR did not have SF. SF occured more frequently in males.
Baseline characteristics
Characteristic
All ISR
limbs
(n66)
Stent
fracture
present
(n25)
Stent
fracture
absent
(n41) p Value
Mean age (years) 72.427.5 72.66.1 72.38.3 0.884
Men 38 (57.6%) 19 (76%) 19 (46.3%) 0.018
Diabetes 37 (56.1%) 15 (60%) 22 (53.7%) 0.615
Smoking 17 (25.8%) 9 (36%) 8 (19.5%) 0.317
Mean stented length (mm) 193.1105 220.8112.2 176.2498.6 0.096
Mean time to ISR (months) 14.57.2 15.27.3 14.17.1 0.548
Mean stent width 6.20.6 6.40.5 6.20.7 0.089
Mean number of stents
implanted
1.90.9 2.11.2 1.80.8 0.256
Median run-off score 5 3 5.5 0.678
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Registry For Immediate And Long Term Follow-up After Endovascular Arterial
Revascularization Of Lower Limbs
Ahmed Emam, MD
King Abdallah Medical City, mekka, Saudi Arabia
Objective: The aim of this registry was to prospectively assess the immediate and long
term outcome of endovascular revascularization for the treatment of lower limb ischemia.
Methods: The outcomes of 87 consecutive procedures in 113 lesions were recorded in
two centers over two years .60 % of patients presented with chronic critical limb ischemia
(CCLI), 40 % of patients with claudication. 35 % of lesions were supra inguinal, 27 %
were infra inguinal lesions and 34 % were infra-genicular lesions. The type of lesions
according to TASC classification were: 40% type A, 30% type B,18% type C and 12%.
type D .Data of this registry were analyzed for immediate angiographic success,
in-hospital morbidities and mortality, limb salvage and one year morbidities and mortality
as well as restenosis by duplex.
Results: The angiographic success rate was 87.4%. 3% of patients had in-hospital
mortality related mainly to the co-morbidities of the peripheral arterial disease; ‘1% cardiac
related, 1% due to septicemia and 1% due to bleeding following gastric stress ulcer; the
immediate in-hospital morbidity occurred in 7% mainly related to access site complica-
tions, 7% minor hematoma, 7% dissection, the need for urgent surgical intervention was
1%. 1 year follow up in 50 patients was as follows: 86 % were alive, 14 % died, septicemia
was a cause of death in 2 %. Recurrence of LL ischemia due to target lesions restenosis
were in 10 % of which only 2 % were CCLI, the need for repeated endovascular
intervention occurred in 4% of patients and surgical revascularization was needed in 2%
only. Limb salvage was 100% .Age and elevated serum creatinine level were independent
predictors for in-hospital mortality.
Conclusion: According to this registry endovascular revascularization of the lower limb
is a good palliative treatment for CCLI, with high success rate, high percentage of limb
salvage and acceptable morbidities including restenosis.
Renal Intervention
CRT-97
Histopathological Characterization Of Renal Arteries After Radiofrequency
Catheter-based Sympathetic Denervation In A Healthy Porcine Model
Michael Joner, Kristin Steigerwald
Deutsches Herzzentrum Muenchen, Munich, Germany
Background: Catheter-based renal artery denervation has successfully been introduced
as alternative treatment for patients suffering drug resistant essential hypertension.
however, the precise mechanisms underlying this technique remain elusive.
Methods and Results: Seven pigs underwent renal artery denervation utilizing the
Simplicity® radiofrequency catheter. both renal arteries were treated in 5 animals, while 2
were treated unilaterally. in bilaterally treated animals, one renal artery was treated at the
index procedure, while the contra-lateral artery was treated 10 days later. renal arteries
were assigned to either the acute (n6), sub-acute (10-day follow-up, n6) or control
(untreated, n2) group. at follow-up blood analysis, final angiography and oct-imaging of
the treated arteries was performed. renal arteries and kidneys were processed for
histopathology and immunohistochemistry.
Radiofrequency derived energy application to the vessel wall induced transmural tissue
coagulation and loss of endothelium resulting in local thrombus formation also detectable
by OCT. At 10 days, the luminal surface was almost completely re-endothelialized. Mural
wall damage was replaced by fibrotic tissue and the adventitial layer showed strong
inflammatory infiltration including vasculogenesis. Remnant nerve fascicles within the
lesion segments of the sub-acute group displayed enhanced vacuolic degeneration,
thickening of the perineurium and an altered neurofilament protein immunostaining
pattern. Examination of the kidneys revealed no abnormalities and blood parameters
remained within the physiological range.
Conclusions: Catheter-based application of radiofrequency energy resulted in circum-
scribed transmural injury within the arterial wall also affecting nerve fascicles in a deferred
manner. acute loss of endothelialization resulted in thrombus formation leaving kidney
perfusion apparently unimpaired.
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